FLSM
Frazier Life Sciences Management’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $138M | Buy |
9,874,511
+1,089,227
| +12% | +$15.3M | 5.54% | 5 |
|
|
2025
Q1 | $137M | Hold |
8,785,284
| – | – | 6.28% | 4 |
|
|
2024
Q4 | $122M | Hold |
8,785,284
| – | – | 5.08% | 5 |
|
|
2024
Q3 | $81.7M | Hold |
8,785,284
| – | – | 3.27% | 11 |
|
|
2024
Q2 | $81.7M | Hold |
8,785,284
| – | – | 3.82% | 8 |
|
|
2024
Q1 | $87.1M | Buy |
8,785,284
+21,052
| +0.2% | +$209K | 3.67% | 9 |
|
|
2023
Q4 | $28.3M | Buy |
8,764,232
+80,000
| +0.9% | +$258K | 1.51% | 19 |
|
|
2023
Q3 | $46.1M | Hold |
8,684,232
| – | – | 3.06% | 11 |
|
|
2023
Q2 | $82.8M | Hold |
8,684,232
| – | – | 4.94% | 7 |
|
|
2023
Q1 | $95.5M | Hold |
8,684,232
| – | – | 6.92% | 4 |
|
|
2022
Q4 | $129M | Hold |
8,684,232
| – | – | 7.99% | 3 |
|
|
2022
Q3 | $166M | Buy |
8,684,232
+250,000
| +3% | +$4.78M | 12.78% | 2 |
|
|
2022
Q2 | $180M | Hold |
8,434,232
| – | – | 16.96% | 1 |
|
|
2022
Q1 | $162M | Buy |
+8,434,232
| New | +$162M | 13.84% | 1 |
|